advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (89)
Showing records 1 to 25
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Tokuda N
Journal of Ophthalmology 2017; 2017: 3540749
74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Kawaguchi I
PLoS ONE 2017; 12: e0186714
74789 Fast Dissolving Dendrimer Nanofiber Mats as Alternative to Eye Drops for More Efficient Antiglaucoma Drug Delivery
Lancina MG
ACS biomaterials science & engineering 2017; 3: 1861-1868
74426 Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis
Nuzzi R
Frontiers in neuroscience 2017; 11: 494
74206 Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery
Qiao X
Journal of Materials Science: Materials in Medicine 2017; 28: 149
74615 Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Di Zazzo A
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 670-677
74115 Application of Imaging Mass Spectrometry to Assess Ocular Drug Transit
Grove KJ
SLAS discovery : advancing life sciences R & D 2017; 22: 1239-1245
74692 High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine
Ianchulev T
Therapeutic delivery 2018; 9: 17-27
74105 Poly(ε-caprolactone) nanocapsule carriers with sustained drug release: single dose for long-term glaucoma treatment
Lee CH
Nanoscale 2017; 9: 11754-11764
74581 Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications
Shen J
Clinical Ophthalmology 2017; 11: 1761-1767
74193 Pure Glaucoma Drugs Are Toxic to Immortalized Human Corneal Epithelial Cells, but They Do Not Destabilize Lipid Membranes
Robciuc A
Cornea 2017; 36: 1249-1255
74544 Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol
Nagai N
Experimental Eye Research 2017; 165: 118-124
74176 Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop
Fedorchak MV
Scientific reports 2017; 7: 8639
74675 Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations
Hsu KH
Pharmaceutical Research 2017; 34: 2862-2872
74481 Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients
Kouchak M
Drug Development and Industrial Pharmacy 2017; 0: 1-16
74394 Development and characterisation of electrospun timolol maleate-loaded polymeric contact lens coatings containing various permeation enhancers
Mehta P
International Journal of Pharmaceutics 2017; 532: 408-420
74115 Application of Imaging Mass Spectrometry to Assess Ocular Drug Transit
Kansara V
SLAS discovery : advancing life sciences R & D 2017; 22: 1239-1245
74394 Development and characterisation of electrospun timolol maleate-loaded polymeric contact lens coatings containing various permeation enhancers
Al-Kinani AA
International Journal of Pharmaceutics 2017; 532: 408-420
74692 High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine
Weinreb R
Therapeutic delivery 2018; 9: 17-27
74544 Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol
Ogata F
Experimental Eye Research 2017; 165: 118-124
74176 Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop
Conner IP
Scientific reports 2017; 7: 8639
74105 Poly(ε-caprolactone) nanocapsule carriers with sustained drug release: single dose for long-term glaucoma treatment
Li YJ
Nanoscale 2017; 9: 11754-11764
74206 Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery
Peng X
Journal of Materials Science: Materials in Medicine 2017; 28: 149
74581 Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications
Goodkin ML
Clinical Ophthalmology 2017; 11: 1761-1767
74675 Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations
Gupta K
Pharmaceutical Research 2017; 34: 2862-2872
